SCHEMBL6515190

SCHEMBL6515190

O=C(Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C(O)C1OC(F)(F)F)c1ccccc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.55
▸ SLC29A1 Q99808 2/20 0.55
▸ ALDH1A1 P00352 1/20 0.55
▸ GLA P06280 1/20 0.55
▸ PMP22 Q01453 1/20 0.55
▸ SMN1; SMN2 Q16637 1/20 0.55
▸ NPC1 O15118 1/20 0.55
▸ NPY1R P25929 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ NPY2R P49146 1/20 0.55
▸ RAB9A P51151 1/20 0.55
▸ RXFP1 Q9HBX9 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ NFKB1 P19838 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ CYP2C19 P33261 1/20 0.55
▸ THPO P40225 1/20 0.55
▸ ADORA1 P30542 7/20 0.55
▸ ADORA3 P0DMS8 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6515178 1.00 LMNA (0.55) LMNASLC29A1ALDH1A1GLAPMP22
SCHEMBL25966446 0.93 PRMT6 (0.51) ADORA1
SCHEMBL25966466 0.91 PRMT6 (0.52) LMNASLC29A1ALDH1A1GLAPMP22
SCHEMBL25966461 0.91 PRMT6 (0.51) LMNASLC29A1ALDH1A1GLAPMP22
SCHEMBL29602480 0.89 MEN1 (0.63) LMNASLC29A1ALDH1A1GLAPMP22
SCHEMBL20454454 0.89 MEN1 (0.63) LMNASLC29A1ALDH1A1GLAPMP22
SCHEMBL19841206 0.89 MEN1 (0.63) LMNASLC29A1ALDH1A1GLAPMP22
SCHEMBL1582757 0.89 MEN1 (0.63) LMNASLC29A1ALDH1A1GLAPMP22
SCHEMBL1582760 0.89 MEN1 (0.63) LMNASLC29A1ALDH1A1GLAPMP22
SCHEMBL29479250 0.88 LMNA (0.57) LMNASLC29A1ALDH1A1GLAPMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050266422-A1 Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides SIRNA THERAPEUTICS, INC. (US) 2005-12-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050266422-A1 Fluoroalkoxy, nucleosides, nucleotides, and polynucleotides NSUN3, IRF3, SNRPF LMNA 4319/4885SLC29A1 553/4885ALDH1A1 3923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback